|
Jun 18
|
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
|
|
Jun 6
|
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
|
|
Jun 2
|
Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome
|
|
May 19
|
Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer
|
|
Feb 21
|
Zealand Pharma AS (ZLDPF) Q4 2024 Earnings Call Highlights: Strong Cash Position and Obesity ...
|
|
Feb 20
|
Zealand Pharma steadfastly upholds amylin-based obesity drug strategy
|
|
Feb 20
|
Zealand Pharma convenes its Annual General Meeting 2025
|
|
Feb 20
|
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
|
|
Feb 20
|
Zealand Pharma Announces Financial Results for the Full Year 2024
|
|
Oct 13
|
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
|
|
Oct 11
|
Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says
|
|
Oct 9
|
FDA declines to approve Zealand Pharma’s hypoglycaemia therapy in infants
|
|
Jul 30
|
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
|
|
Jul 29
|
Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
|
|
Jun 25
|
Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion
|
|
Jun 25
|
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion
|
|
Jun 25
|
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
|
|
Jun 24
|
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?
|
|
Jun 21
|
Existing home sales, a day with Fed's Susan Collins: Catalysts
|
|
Jun 21
|
Zealand Pharma's Weight Loss Drug Performs Well in Early Trials
|